Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (Background paper)
Book dossier
Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (Background paper)
by Alan M. Garber
No description is available for this edition yet.
No online reader is advertised for this title
United StatesGaucher's diseaseTreatmentPharmaceutical policyOrphan drugsGaucher diseaseDrug therapyGlucosylceramidaseTherapeutic useOrphan Drug Production
